Cargando…
Adiponectin as a novel biomarker of disease severity in alopecia areata
The frequent coexistence of obesity and metabolic syndrome in patients with alopecia areata may indicate the common pathogenetic pathway in these conditions with an important role of adipokines. The aim of the study was to evaluate the serum level of adiponectin, resistin and leptin in patients with...
Autores principales: | Stochmal, Anna, Waśkiel-Burnat, Anna, Chrostowska, Sylwia, Zaremba, Michał, Rakowska, Adriana, Czuwara, Joanna, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257783/ https://www.ncbi.nlm.nih.gov/pubmed/34226603 http://dx.doi.org/10.1038/s41598-021-92853-1 |
Ejemplares similares
-
Lipocalin-2 and insulin as new biomarkers of alopecia areata
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2022) -
Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
por: Rudnicka, Lidia, et al.
Publicado: (2021) -
Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2023) -
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
por: Papierzewska, Małgorzata, et al.
Publicado: (2023) -
Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2021)